October 16, 2013
Vancouver, BC and Seattle, WA - The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics Inc. will use their biomarker expertise in collaboration with the Jain Foundation, Inc. to identify blood-based biomarkers of disease in individuals with a rare form of muscular dystrophy, called Limb?girdle muscular dystrophy 2B (LGMD2B) [...]
October 15, 2013
Redwood City, California, and Hilden, Germany -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the Empowered Genome Community, which is a first-of-its-kind initiative to help people who have had their genomes sequenced share, explore, and interpret their data with researchers and each other. To highlight how the community can spark new biomedical [...]
GenoLogics Announces No-cost Clarity Cloud Edition
October 15, 2013
Victoria, BC, Canada –– GenoLogics Life Sciences Software, a leading provider of laboratory information management systems (LIMS) announced today the availability of three new cloud-based lab management products: Clarity Run Manager, Clarity Run Manager Plus, and the early access availability of Clarity LIMS Silver. These editions are sized and priced to fit any genomics laboratory’s [...]
Vitro Biopharma Announces Plans to Acquire & Merge with Neuromics, Inc.
October 15, 2013
Golden, Colorado -- Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, signed a non-binding letter of intent to acquire and merge with Neuromics, Inc, a privately held life-science firm located in Minneapolis, MN. The Merger would be structured as a reverse triangular merger, with Neuromics becoming a wholly-owned subsidiary of Vitro. Completion of the proposed [...]
October 15, 2013
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on how AFM and advanced fluorescence microscopy is being applied in the study of biological membranes in the Centre de Biochimie Structurale (CBS, CNRS and INSERM affiliated) in Montpellier (France). The CBS includes a research group focused on [...]
October 15, 2013
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX), and its subsidiary OncoCyte Corporation today announced that OncoCyte has entered into a Sponsored Research Agreement and a Material Transfer Agreement with The Wistar Institute to collaboratively develop lung cancer diagnostic products. As part of the collaboration, Wistar investigators are conducting a multi-center patient study in which [...]
Pall Opens New Life Sciences Centre of Excellence in Shanghai China
October 15, 2013
SHANGHAI - Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today inaugurated the Pall Life Sciences Centre of Excellence (CoE) at its new Zhangjiang site in Shanghai in the People’s Republic of China. The new Centre of Excellence, which offers biopharmaceutical process solutions, technical and validation support as well as training, extends [...]
October 15, 2013
PARSIPPANY, NJ and OMAHA, NE – PDI, Inc. (Nasdaq: PDII) and Transgenomic, Inc. (OTCBB: TBIO), today announced the signing of a U.S. collaboration agreement to commercialize CardioPredict™, a molecular diagnostic test developed by Transgenomic. CardioPredict™ is a broad-based genetic assay which identifies a patient’s specific genes that influence the effectiveness and safety of many commonly [...]
Fluxion launches High Throughput Quattro Array for BioFlux™
October 15, 2013
South San Francisco, Calif. -- Fluxion Biosciences announced today that it has launched its BioFlux Quattro High Throughput Array System for physiologically relevant live cell analysis. The system is now commercially available and shipping to customers. The Quattro Array system is sold as a separate component and can expand the capabilities of any existing BioFlux [...]
Licensing deal marks coming of age for UAB-UW nanopore sequencing technology
October 15, 2013
The University of Alabama at Birmingham today announced that Illumina Inc. has licensed the rights to a DNA sequencing technology developed by a UAB microbiologist and a University of Washington physicist. The patent-licensing deal revolves around nanopores first studied as potential chinks in the armor of the tuberculosis bacteria, but now part of efforts to [...]

